Published in Mol Biol Rep on February 15, 2012
Lipoprotein metabolism in nonalcoholic fatty liver disease. J Biomed Res (2012) 0.90
The Role of Clinical Proteomics, Lipidomics, and Genomics in the Diagnosis of Alzheimer's Disease. Proteomes (2016) 0.85
Genetic background in nonalcoholic fatty liver disease: A comprehensive review. World J Gastroenterol (2015) 0.84
A case-control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease. Genes Nutr (2014) 0.81
Apolipoprotein E gene variants on the risk of end stage renal disease. PLoS One (2013) 0.77
Systematic review of genetic association studies involving histologically confirmed non-alcoholic fatty liver disease. BMJ Open Gastroenterol (2015) 0.77
Early-life enteric infections: relation between chronic systemic inflammation and poor cognition in children. Nutr Rev (2016) 0.76
Field-practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in Italy. Hepatology (2011) 4.60
Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med (2005) 4.57
Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology (2009) 4.16
Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev (2009) 3.33
Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center. Alcohol Clin Exp Res (2013) 2.84
Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study. Blood (2004) 2.64
Vascular and neoplastic risk in a large cohort of patients with polycythemia vera. J Clin Oncol (2005) 2.50
Revision of the European Data Protection Directive: opportunity or threat for public health monitoring? Eur J Public Health (2011) 2.40
Management of alcohol dependence in patients with liver disease. CNS Drugs (2013) 2.35
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol (2009) 2.14
Risk factors for intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a multicentre case-control study. Am J Gastroenterol (2013) 2.11
The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease. Gastroenterology (2008) 2.04
Telemedicine for the reduction of myocardial infarction mortality: a systematic review and a meta-analysis of published studies. Telemed J E Health (2012) 2.03
Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial. Alcohol Alcohol (2011) 1.98
The relationship between avoidable hospitalization and accessibility to primary care: a systematic review. Eur J Public Health (2012) 1.91
Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity. J Hepatol (2010) 1.78
Cigarette, cigar, and pipe smoking and the risk of head and neck cancers: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Am J Epidemiol (2013) 1.73
Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment. World J Gastroenterol (2010) 1.69
A genome-wide association study of upper aerodigestive tract cancers conducted within the INHANCE consortium. PLoS Genet (2011) 1.68
A systematic review evaluating the methodological aspects of meta-analyses of genetic association studies in cancer research. Eur J Epidemiol (2010) 1.66
Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound. J Hepatol (2013) 1.62
Health systems and policy research in Europe: Horizon 2020. Lancet (2013) 1.59
The Health Technology Assessment of bivalent HPV vaccine Cervarix in Italy. Vaccine (2010) 1.54
Acute cholestatic hepatitis associated with celecoxib. Ann Pharmacother (2002) 1.53
Image-enhanced endoscopy with I-scan technology for the evaluation of duodenal villous patterns. Dig Dis Sci (2012) 1.52
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome. Clin Endocrinol (Oxf) (2011) 1.45
Severe acute hepatitis after resumption of interferon-Beta therapy for multiple sclerosis: a word of caution. Am J Gastroenterol (2007) 1.42
Health technology assessment agencies: an international overview of organizational aspects. Int J Technol Assess Health Care (2007) 1.39
Knowledge, attitudes and behavior of physicians regarding predictive genetic tests for breast and colorectal cancer. Prev Med (2013) 1.32
Legionella contamination in hot water of Italian hotels. Appl Environ Microbiol (2005) 1.29
Socioeconomic disparities in the uptake of breast and cervical cancer screening in Italy: a cross sectional study. BMC Public Health (2012) 1.29
Identification and characterization of a Cryptococcus neoformans ATP binding cassette (ABC) transporter-encoding gene, CnAFR1, involved in the resistance to fluconazole. Mol Microbiol (2003) 1.25
The haematocrit and platelet target in polycythemia vera. Br J Haematol (2006) 1.25
Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome. Semin Thromb Hemost (2009) 1.23
Universal health coverage: a quest for all countries but under threat in some. Value Health (2012) 1.23
Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk. Int J Epidemiol (2009) 1.22
Tobacco use prevalence, knowledge and attitudes among Italian hospital healthcare professionals. Eur J Public Health (2010) 1.18
CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer. J Cancer Res Clin Oncol (2007) 1.15
Epstein syndrome: another renal disorder with mutations in the nonmuscle myosin heavy chain 9 gene. Hum Genet (2001) 1.15
An ecological study on the relationship between supply of beds in long-term care institutions in Italy and potential care needs for the elderly. BMC Health Serv Res (2009) 1.13
An assessment of the effect of hepatitis B vaccine in decreasing the amount of hepatitis B disease in Italy. Virol J (2008) 1.13
The effectiveness of computerized clinical guidelines in the process of care: a systematic review. BMC Health Serv Res (2010) 1.13
Acute hepatitis caused by a natural lipid-lowering product: when "alternative" medicine is no "alternative" at all. J Hepatol (2009) 1.12
Biofilm demolition and antibiotic treatment to eradicate resistant Helicobacter pylori: a clinical trial. Clin Gastroenterol Hepatol (2010) 1.11
Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls. Eur J Epidemiol (2013) 1.09
Faecal calprotectin concentrations in untreated coeliac patients. Scand J Gastroenterol (2007) 1.09
A 360-degree overview of paediatric NAFLD: recent insights. J Hepatol (2012) 1.08
A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease. BMC Cancer (2009) 1.08
Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial. Free Radic Biol Med (2012) 1.07
Meta-analysis of the brain-derived neurotrophic factor gene (BDNF) Val66Met polymorphism in anxiety disorders and anxiety-related personality traits. Neuropsychobiology (2008) 1.06
Polymyalgia rheumatica in 2011. Best Pract Res Clin Rheumatol (2012) 1.05
Cardiopulmonary resuscitation alone vs. cardiopulmonary resuscitation plus automated external defibrillator use by non-healthcare professionals: a meta-analysis on 1583 cases of out-of-hospital cardiac arrest. Resuscitation (2007) 1.03
Smoking status and gastric cancer risk: an updated meta-analysis of case-control studies published in the past ten years. Tumori (2009) 1.02
Prevention of thrombosis in polycythemia vera and essential thrombocythemia. Haematologica (2008) 1.01
The role of IL-15 in gastrointestinal diseases: a bridge between innate and adaptive immune response. Cytokine Growth Factor Rev (2013) 1.01
Evidence-based policy? The use of mobile phones in hospital. J Public Health (Oxf) (2006) 1.00
Development and validation of an in-house database for matrix-assisted laser desorption ionization-time of flight mass spectrometry-based yeast identification using a fast protein extraction procedure. J Clin Microbiol (2014) 1.00
The financial crisis in Italy: implications for the healthcare sector. Health Policy (2012) 1.00
Catheter-related candidemia caused by Candida lipolytica in a patient receiving allogeneic bone marrow transplantation. J Clin Microbiol (2002) 1.00
Glutathione S-transferase M1 status and gastric cancer risk: a meta-analysis. Cancer Lett (2005) 0.99
OPTIGOV - A new methodology for evaluating Clinical Governance implementation by health providers. BMC Health Serv Res (2010) 0.99
Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma. Hepatology (2013) 0.99
Patterns of Long Term Care in 29 European countries: evidence from an exploratory study. BMC Health Serv Res (2011) 0.98
Diet and the risk of head and neck cancer: a pooled analysis in the INHANCE consortium. Cancer Causes Control (2011) 0.98
Polymorphisms in metabolic genes, their combination and interaction with tobacco smoke and alcohol consumption and risk of gastric cancer: a case-control study in an Italian population. BMC Cancer (2007) 0.98
Prophylaxis against venous thromboembolism in patients with cancer. N Engl J Med (2014) 0.97
Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test. Am J Gastroenterol (2003) 0.97
A systematic review of meta-analyses on gene polymorphisms and gastric cancer risk. Curr Genomics (2008) 0.97
Hepatitis C Virus infections trends in Italy, 1996-2006. Hepat Mon (2011) 0.97
Meta-analysis and pooled analysis of GSTM1 and CYP1A1 polymorphisms and oral and pharyngeal cancers: a HuGE-GSEC review. Genet Med (2008) 0.97
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. J Hepatol (2009) 0.95
Gut-liver axis and microbiota in NAFLD: insight pathophysiology for novel therapeutic target. Curr Pharm Des (2013) 0.95
Cellular mediators of inflammation: tregs and TH17 cells in gastrointestinal diseases. Mediators Inflamm (2010) 0.94
Extra-curricular physical activity and socioeconomic status in Italian adolescents. BMC Public Health (2006) 0.94
Glucokinase links Krüppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease. Hepatology (2012) 0.94
Abdominal angina. Am J Med Sci (2009) 0.93
Lifestyle interventions in patients with coronary heart disease: a systematic review. Am J Prev Med (2013) 0.92
Transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma in cirrhotics: functional hepatic reserve and survival. Hepatogastroenterology (2003) 0.92
Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels. Clin Endocrinol (Oxf) (2012) 0.92
A case-control study on the effect of p53 and p73 gene polymorphisms on gastric cancer risk and progression. Mutat Res (2009) 0.92
Evaluation of the Endorsement of the STrengthening the REporting of Genetic Association Studies (STREGA) Statement on the Reporting Quality of Published Genetic Association Studies. J Epidemiol (2016) 0.92
'Doctor, treat your patient, not your monitor!' Tremor-induced ECG artefacts mimicking torsades de pointes. BMJ Case Rep (2014) 0.91
A case-control study on the combined effects of p53 and p73 polymorphisms on head and neck cancer risk in an Italian population. BMC Cancer (2009) 0.91